Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis

European Journal of Preventive Cardiology

Volumn 16, Issue 3, 2009, Pages 325-332

  Conraads, Viviane Marie ^a   Hoymans, Vicky Y ^a   Vermeulen, Tinie ^a   Beckers, Paul ^a   Possemiers, Nadine ^a   de Maeseneer, Marianne ^a   Vrints, Christiaan ^a   Martinet, Wim ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

apoptosis; chronic heart failure; exercise capacity; exercise training; skeletal muscle; transcription; wasting

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEINASE K; SPIRONOLACTONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SC 35; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTION; ENDURANCE; EXERCISE; FEMALE; GENETIC TRANSCRIPTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; MALE; MUSCLE BIOPSY; NICK END LABELING; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RNA SPLICING; SITTING; SKELETAL MUSCLE; TREATMENT DURATION;

APOPTOSIS; ARTIFACTS; BIOPSY; CASPASE 3; CHRONIC DISEASE; EXERCISE THERAPY; FALSE POSITIVE REACTIONS; FEMALE; HEART FAILURE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; REPRODUCIBILITY OF RESULTS; RESISTANCE TRAINING; RIBONUCLEOPROTEINS; TIME FACTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 70349218445     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283244436     Document Type: Article

References (24)

1. Franciosa JA, Baker BJ, Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 1985; 110: 807–813.
2. Adams V, Doring C, Schuler G. Impact of physical exercise on alterations in the skeletal muscle in patients with chronic heart failure. Front Biosci 2008; 13: 302–311.
3. Conraads VM, Hoymans VY, Vrints CJ. Heart failure and cachexia: insights offered from molecular biology. Front Biosci 2008; 13: 325–335.
4. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997; 30: 1758–1764.
5. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 1996; 27: 140–145.
6. Drexler H, Riede U, Münzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1751–1759.
7. Hambrecht R, Fiehn E, Yu JT, Niebauer J, Weigl C, Hilbrich L, et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997; 29: 1067–1073.
8. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81: 518–527.
9. Conraads V, Bosmans J, Vrints C. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol 2002; 85: 33–49.
10. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. N Eng J Med 1996; 335: 1897–1905.
11. Adams V, Mangner N, Gasch A, Krohne C, Gielen S, Hirner S, et al. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. J Mol Biol 2008 [Epub ahead of print].
12. Vescovo G, Volterrani M, Zennaro R, Sandri M, Ceconi C, Lorusso R, et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000; 84: 431–437.
13. Adams V, Jiang H, Yu J, Möbius-Winkler S, Fiehn E, Linke A, et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 1999; 33: 959–965.
14. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, et al. Antioxidative effects of exercise training in patients with chronic heart failure. Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111: 1763–1770.
15. Kockx MM, Muhring J, Knaapen MWM, De Meyer GRY. RNA synthesis and splicing interfere with DNA in situ end labelling techniques used to detect apoptosis. Am J Pathol 1998; 152: 885–888.
16. Wassermann K, Beaver L, Whipp BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 1990; 81 (Suppl):II14–II30.
17. Dalla Libera L, Zennaro R, Sandri M, Ambrosio GB, Vescovo G. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol 1999; 277: C982–C986.
18. Harrington D, Anker SD, Coats AJ. Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J 2001; 22: 392–399.
19. Schaper J, Elsässer A, Kostin S. The role of cell death in heart failure. Circ Res 1999; 85: 867–869.
20. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999; 99: 2757–2764.
21. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ. Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 1999; 34: 1170–1175.
22. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25: 1797–1805.
23. Conraads VM, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, Brutsaert DL. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002; 23: 1854–1860.
24. Hein S, Arnon E, Kostin S, Schönburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107: 984–991.